{
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "physical",
    "ucits": false,
    "type": "ETP",
    "complex_factors": [
        "3x inverse leverage",
        "Daily rebalancing with compounding effects",
        "Short-term trading focus (1-day holding period)",
        "High risk profile (risk level 7/7)",
        "Complex underlying index (ARK Innovation ETF with thematic investments)",
        "Potential for significant tracking error due to compounding"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to several key factors: 1) 3x inverse leverage creates significant risk amplification and potential for rapid losses; 2) Daily rebalancing with compounding effects makes returns unpredictable over longer periods; 3) The recommended holding period of just 1 day indicates this is designed for short-term trading, not long-term investing; 4) The underlying ARK Innovation ETF invests in highly volatile thematic areas (DNA tech, AI, fintech) which adds another layer of complexity; 5) The risk indicator of 7/7 (highest possible) confirms the product's high-risk nature. While the replication method is physical (owning the underlying), the inverse leverage and short-term trading focus make this unsuitable for retail investors without sophisticated understanding. The PRIIPs KID confirms this with warnings about daily monitoring requirements and the potential for losses to exceed initial investment. The fact sheet mentions 'physical replication' but this refers to the short positions being held directly rather than using swaps, which doesn't reduce the overall complexity of the product.",
    "confidence": 95
}